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Summary
Patella aplasia-hypoplasia (PTLAH) is a rare genetic de-
fect characterized by congenital absence or marked re-
duction of the patella. PTLAH can occur either as an
isolated defect or in association with other malforma-
tions, and it characteristically occurs in the nail-patella
syndrome and in some chromosome imbalances. We re-
port the first evidence of linkage for isolated PTLAH in
an extended Venezuelan family. After exclusion of the
candidate chromosome regions where disorders associ-
ated with PTLAH have been mapped, a genomewide
scan was performed that supported mapping of the dis-
ease locus within a region of 12 cM on chromosome
17q22. Two marker loci (D17S787 and D17S1604)
typed from this region gave maximum LOD scores 13.
Accordingly, multipoint analysis gave a maximum LOD
score of 3.39, with a most likely location for the disease
gene between D17S787 and D17S1604. Sequencing of
the noggin gene, a candidate mapping between these
markers, failed to reveal any mutation in affected sub-
jects.
Introduction
Patella aplasia-hypoplasia (PTLAH [MIM 168860]) is a
rare genetic defect characterized by congenital absence
or marked reduction of the patella bone. PTLAH can
occur either as an isolated defect or in association with
other malformations. Familial isolated PTLAH has been
reported in only a few pedigrees, showing an autosomal
dominant inheritance (Kutz 1949; Bernhang and Levine
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1973; Braun 1978). Association of PTLAH with other
defects, including coxa vara and tarsal synostosis, mal-
formed pelvic girdle, and upper femora aniridia, has
been observed (Goeminne and Dujardin 1970; Mirkin-
son andMirkinson 1975; Scott and Taor 1979). Aplastic
or hypoplastic patella occurs in distinct disorders, in-
cluding Coffin-Siris syndrome, Kuskokwin syndrome,
and trisomy 8 syndrome (Petajan et al. 1969; Wright
1970; Cassidy et al. 1975; Fineman et al. 1975; Silengo
et al. 1979; Lucaya et al. 1981; Sujansky et al. 1981;
Gorlin 1990). At present, a single gene (LMX1B) coding
for a protein involved in the patella development has
been cloned (Dreyer et al. 1998). This protein is a mem-
ber of a diverse family of regulatory proteins character-
ized by the presence of two zinc-finger structures and a
homeodomain (Curtiss and Heilig 1998). Mutations of
the LMX1B gene have been detected in patients affected
by nail-patella syndrome (NPS [MIM *161200]), a plei-
otropic disorder presenting with dysplastic nails, absent
or hypoplastic patella, exostoses of the ilia, dysplasia of
the elbows, and, in some cases, nephropathy (Beals and
Eckhardt 1969; Dreyer et al. 1998; McIntosh et al.
1998). We have investigated a four-generation family,
segregating an autosomal dominant, isolated PTLAH
and localizing the gene responsible for this defect to
chromosome 17q21–22, by genomewide scanning.
Subjects and Methods
Family Recruitment
The investigated family is of Venezuelan ancestry and
includes 26 members affected by isolated PTLAH (fig.
1). Each family member who agreed to participate in
the present study was examined. Individuals were scored
as affected if they had clinical and radiographic evidence
of bilateral absent patella. Thus, clinical status was de-
termined unequivocally for all participating familymem-
bers. The study was approved by the institutional review
boards of the Tor Vergata (Rome) and Oriente (Ciudad
Bolivar) Universities, and appropriate informed consent
was obtained for all subjects.
Figure 1 Pedigree of the initial branch of the kindred studied. Unblackened circles and squares indicate members who are unaffected. Blackened circles and squares indicate members reported
to be affected. A degree symbol () indicates tested individuals.
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Figure 2 Radiographic screening of the knees of three affected
members (IV-6, V-2, and IV-12). A, Lateral projection (view) of the
right knee of an 8-year-old boy (IV-6) with absence of the ossification
center of the patella. B, Axial projection (view) for the patella of a
10-year-old (V-2) subject in which the ossification center of the patella
is absent bilaterally. C, D, Evidence of patella hypoplasia in a 25-year-
old subject (IV-12).
Genotyping
Genomic DNA was extracted from the whole blood
according to a standard protocol, quantified spectro-
photometrically, and used at a concentration of 50 ng/
ml. Markers D9S112, D9S315, D9S159, D9S195, PAX
6 (amplified by intragenic primers B509–B507), and
HUMTH01 were selected on the basis of their demon-
strated high LOD scores with respect to NPS and an-
iridia (Jordan et al. 1992; McIntosh et al. 1997). Chro-
mosome 8q markers (D8S270, D8S276, D8S269,
D8S272, D8S65, D8S53, and D8S44) were selected from
the Ge´ne´thon database (Weissenbach et al. 1992). Ge-
nome scanning was performed with 358 microsatellite
markers loci from ABI PRISM Linkage Mapping Set (PE
Applied Biosystems) at a distance of ∼10 cM. PCR was
performed with 50 ng of DNA in a 15-ml reaction mix-
ture containing 1.5 ml buffer (100 mM Tris HCl, pH
8.3, 500 mMKCl), 1.5 ml MgCl2 (25 mM), 1.5 ml dNTPs
mix (2.5 mM), 1 ml primer mix (5 mM), and 0.6 U of
AmpliTaq Gold (PE Applied Biosystems). PCR products
were analyzed on a model 310 automated fluorescent
DNA sequencer (PE Applied Biosystems), a four-color
detection system. One microliter of PCR reaction mix-
ture was combined with 20 ml of formamide and 0.5 ml
of a fluorescent size marker (TAMRA GS-500; PE Ap-
plied Biosystems). Each sample was run for 30 min. Dur-
ing electrophoresis, the fluorescence detected in the laser
scanning region was collected and stored with GENES-
CAN collection software (version 3.1; PE Applied Bios-
ystems). The fluorescence data collected during the run
were analyzed automatically by the GENESCAN anal-
ysis program (PE Applied Biosystems) at the end of each
run. Each marker was examined by the GENOTYPER
program (version 2.0; PE Applied Biosystems) to analyze
inheritance patterns and to prepare the allele labels for
export to linkage applications.
Linkage Analysis
Linkage analysis was performed with the LINKAGE
5.1 computer program package (Lathrop and Lalouel
1984). Two-point LOD scores between the disease gene
and each marker were calculated by means of the
MLINK program (see Lathrop and Lalouel 1984). The
phenotype was coded as a fully penetrant autosomal
dominant trait with a disease allele frequency of .0001.
Equal recombination frequencies for men and women
were assumed. The order of the markers’ loci and their
recombination distances used for multipoint linkage
analysis were based on the Ge´ne´thon linkage map (Weis-
senbach et al. 1992; Gyapay et al. 1994; Dib et al. 1996).
Multipoint analysis was performed by the VITESSE
computer program (O’Connell and Weeks 1995).
Candidate Gene Analysis
The noggin cDNA sequence (Valenzuela et al. 1995)
was used to design primers NOG1 (corresponding to nt
770–790) and NOG5 (corresponding to nt 1550–1531),
which amplify a 780-bp product containing the entire
coding sequence (included in a single exon) plus 400 bp
of the 5′ UTR. After gel purification, each sample was
sequenced with the Thermo-Sequenase cycle-sequencing
kit (Amersham Life Sciences) with IRD-41–labeled prim-
ers (Maceratesi et al. 1996), according to the manufac-
turer’s instructions. Sequences were then run on a LI-
COR 4000L automated sequencer (LI-COR).
Results
Clinical Presentation
The family included 26 members affected by isolated
PTLAH (fig. 1). The proband (III-7) was clinically eval-
uated after a routine medical examination for an un-
related disease. On clinical inspection, bilateral absent
patella was suspected, which was confirmed by radio-
graphic study (fig. 2). The patient indicated that several
other family members presented similar discomfort at
knee articulation (fig. 2). Direct clinical and radiographic
evaluations were performed in 15 affected subjects,
whereas isolated PTLAHwas assumed also to be present
in 11 additional persons on the basis of anamnestic in-
Figure 3 Haplotypes of seven DNA markers on 17q in the examined branch of the family. Unblackened circles and squares indicate members who are unaffected. Blackened circles and squares
indicate members reported to be affected. A degree symbol () indicates tested individuals. The blackened sections of the bars indicate the haploidentical region in affected individuals, which defines
the critical PTLAH region between flanking markers D17S925 and D17S808.
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Table 1
Two-point LOD Scores at Seven Polymorphic Markers on
Chromosome 17q
Marker
LOD SCORE AT v 
.00 .01 .03 .05 .10 .20 .30
D17S925  1.02 .52 .29 .008 .19 .21
D17S798  .28 .15 .31 .46 .41 .25
D17S809  .55 .28 .61 .90 .88 .61
D17S787 3.34 3.27 3.13 2.99 2.64 1.89 1.13
D17S1604 3.17 3.12 3.01 2.90 2.60 1.98 1.30
D17S1838  2.61 1.69 1.28 .76 .33 .13
D17S808  1.29 1.67 1.79 1.84 1.56 1.12
Figure 4 Multipoint LOD-score analysis for the region
17q21–22. The multipoint linkage analysis localized the locus for
PTLAH within an interval of ∼8 cM between markers D17S787 and
D17S1604. The multipoint LOD score throughout this interval was
3.39.
vestigations. During clinical inspection, aplastic patella
was identified by the occurrence of a dimple, when legs
were maintained in a closed flexed position, at the po-
sition corresponding to the anatomic site of the patella.
Hypoplastic patellas were easily identified by manual
palpation by their reduced sizes compared with patellas
in unaffected individuals. Anatomic lesions were always
bilateral. Clinical diagnosis was never questioned.
Fourteen of the 15 affected people examined com-
plained only of minor discomfort related to the patella
defect. The most severely affected subject (III-1) showed
an abnormal gait, whereas walking was generally nor-
mal in other affected individuals. They complained of
some difficulties with running, with stopping abruptly,
with climbing the stairs, and with riding a bike. During
childhood, some of them had experienced unexpected
falls while walking, without additional problems. The
general feeling of these persons was that they had in-
herited a condition that interfered only minimally with
a normal lifestyle. One affected girl died at age 15 years
of a cerebral aneurysm, confirmed by autopsy. No ob-
vious internal malformations were found. On physical
examination, no additional defect was found in this fam-
ily, except unilateral 4th–5th syndactyly in a single sub-
ject (IV-12). In particular, no tarsal synostosis, nail dys-
plasia, or other dysmorphic features were present in the
patients. Auxologic parameters were within normal lim-
its, and no evidence of neurologic alterations or mental
retardation was detected. Pelvic bones were normal.
Linkage Analysis
Because PTLAH is a major characteristic of a number
of disorders, including NPS, aniridia, and trisomy 8q
syndrome, linkage studies were first done with markers
from these candidate regions. However, this analysis
failed to support the location of the disease-gene on
chromosome 9q, 11p, or 8q (LOD scores of  at re-
combination fraction [v] 0 were obtained at all loci). A
linkage genomewide screen was conducted with micro-
satellite markers at intervals of ∼10 cM, and a first LOD
score of 3.14 at for the marker at locus D17S1604v  0
was obtained. Subsequently, a LOD score of 3.34 at
was achieved for the marker at locus D17S787.v  0
Two-point LOD scores for seven additional markers
from the region are given in table 1. A haplotype analysis
was also done with sevenmarkers in the interval between
D17S925 and D17S808 (fig. 3). Five informative recom-
bination events were observed in this region and allowed
us to narrow down the possible locations of the disease
gene. In affected individual IV-6 and in unaffected in-
dividual IV-25, a recombination event had occurred be-
tween D17S809 and D17S787, establishing the cen-
tromeric limit for the candidate region. A recombination
event in the affected subjects III-1 and V-2 and in the
unaffected V-3 subjects defined the telomeric boundary.
Recombination mapping thus defines a 12-cM interval
that must contain the PTLAH gene. This is consistent
with results of multipoint analysis, which gave a max-
imum LOD score of 3.39, with a most likely location
for the disease gene between D17S787 and D17S1604
(fig. 4).
Candidate Gene Analysis
Being closely linked to D17S787 (Gong et al. 1999),
the noggin gene was evaluated as a first PTLAH can-
didate gene. A 780-bp fragment that included the nog-
gin-gene single exon and part of the 5′ UTR (∼400 bp)
was amplified and sequenced in two affected and two
unaffected family members. No mutations were found
in the affected patient (fig. 5).
Discussion
We present a four-generation Venezuelan family with
isolated PTLAH transmitted as an autosomal dominant
mutation. We excluded linkage to the candidate chro-
mosome regions 9q34, 11p, and 8q, where disorders
associated with PTLAH have been mapped. In partic-
ular, exclusion of the NPS locus on chromosome 9q34
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Figure 5 Comparative sequence analysis of the coding region of
the noggin gene in patient IV:4 (lanes A1, C1,G1, and T1) and a normal
control (lanes A2, C2, G2, and T2).
confirms that PTLAH is not allelic to NPS. Additional
features that occur in 190% of patients with
NPS—including nail dysplasia, a single iliac horn on
each side, and elbow deformities—are never found in
association with PTLAH (Azouz and Kozlowski 1997).
In this family, recombination studies and a multipoint
analysis mapped the PTLAH gene within a 12-cM in-
terval at 17q21–22. Genes mapped in the 17q21–22
region include the nucleolar transcription factor, cyclin
A, and myeloperoxidase precursor gene, which are not
likely candidates for a disorder of bone, being general-
housekeeping genes (Krakow et al. 1998). Of interest,
the region 17q21–22 includes DLX3 and DLX7, two
members of the distalless gene family that encode de-
velopmental proteins expressed in neuronal and skeletal
tissues (Nakamura et al. 1996). We considered the pos-
sibility that both DLX3 and DLX7 are PTLAH candi-
date genes. However, a recombination event in the family
we studied excludes the region where these two genes
are located. Thus it is unlikely that mutations in one of
these two genes results in PTLAH. Of interest, Gong et
al. (1999) have identified five dominant mutations
within the human noggin gene in unrelated families seg-
regating proximal symphalagism (SYM1 [MIM
185800]), a disease involving joint abnormalities. Be-
cause Gong et al. have positioned noggin between mark-
ers D17S790 and D17S794, we analyzed the complete
coding sequence and part of the 5′ UTR region of this
gene in patients with PTLAH, to determine whether the
gene is involved in the pathogenesis of PTLAH. Sequence
analysis revealed a complete absence of mutations. We
are currently recruiting additional pedigrees, to narrow
down the critical region and to verify genetic homoge-
neity of familiar PTLAH.
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